7 statistics on colorectal cancer in the US — 50k+ deaths expected in 2018

In 2018, colorectal cancer is expected to be the third leading cause of cancer-related deaths in the U.S., according to the American Cancer Society.

Here are seven things to know about colorectal cancer:

1. The American Cancer Society projects 50,630 colorectal cancer-related deaths in 2018.

2. Although the death rate for men and women with colorectal cancer has been dropping, 4.49 percent of men and 4.15 percent of women are at risk of developing colorectal cancer within their lifetime.

3. In 2018, the ACS expects 97,220 new cases of colon cancer and 43,030 new cases of rectal cancer.

4. The five-year survival rates for colon cancers are:

• Stage I: 92 percent
• Stage IIA: 87 percent
• Stage IIB: 63 percent
• Stage IIIA: 89 percent
• Stage IIIB: 69 percent
• Stage IIIC: 53 percent
• Stage IV: 11 percent

5. The five-year survival rates for rectal cancers are:

• Stage I: 87 percent
• Stage IIA: 80 percent
• Stage IIB: 49 percent
• Stage IIIA: 84 percent
• Stage IIIB: 71 percent
• Stage IIIC: 58 percent
• Stage IV: 12 percent

6. The eight states with the lowest colorectal cancer screening rates among adults 50 years and older are:
https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2017-2019.pdf

• Wyoming: 58 percent
• Oklahoma: 59 percent
• Alaska: 61 percent
• Arkansas: 62 percent
• Idaho: 62 percent
• Illinois: 62 percent
• Mississippi: 62 percent
• Nevada: 62 percent

7. Non-Hispanic black populations have the highest colorectal cancer mortality rates, at 49.2 percent; American Indian and Alaskan Native populations have a 45.7 percent mortality rate and Non-Hispanic white individuals have a 40.2 percent mortality rate from colorectal cancer.

More articles on gastroenterology:
Capital Digestive Care implements gGastro Cloud—5 insights
The Center for Digestive Health receives ASGE Endoscopy Unit Recognition
The biggest issues in GI & what Gastro Health has in store for 218—Dr. James Leavitt shares insights

 

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months